Carbidopa-assisted (18)F-fluorodihydroxyphenylalanine PET/CT for the localization and staging of non-functioning neuroendocrine pancreatic tumors.
Fiche publication
Date publication
novembre 2016
Journal
Annals of nuclear medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BACHELLIER Philippe, Pr NAMER Izzie-Jacques
Tous les auteurs :
Helali M, Addeo P, Heimburger C, Detour J, Goichot B, Bachellier P, Namer IJ, Taïeb D, Imperiale A
Lien Pubmed
Résumé
CD premedication was found to increase the value of (18)F-fluorodihydroxyphenylalanine ((18)F-FDOPA) PET/CT imaging in the detection of adult insulinoma. The aim of this study was to evaluate the performance of CD-assisted (18)F-FDOPA PET/CT in the diagnosis and staging of non-functioning pNETs.
Mots clés
Adult, Aged, Carbidopa, pharmacology, Dihydroxyphenylalanine, analogs & derivatives, Female, Humans, Male, Middle Aged, Neoplasm Staging, Neuroendocrine Tumors, diagnostic imaging, Pancreatic Neoplasms, diagnostic imaging, Positron Emission Tomography Computed Tomography, methods
Référence
Ann Nucl Med. 2016 Nov;30(9):659-668